In vivo imaging as a pharmacodynamic marker

Astrid A M van der Veldt1, Adriaan A Lammertsma2

  • 1Authors' Affiliations: Departments of Internal Medicine, Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the NetherlandsAuthors' Affiliations: Departments of Internal Medicine, Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands aam.vanderveldt@vumc.nl.

Summary

Positron emission tomography (PET) with radiolabeled anticancer drugs like paclitaxel and docetaxel helps understand drug behavior. This approach aids in personalized cancer treatment planning and developing new radiolabeled therapies.